IDiyas

For the Inventor, By the Inventor

Sutton, United Kingdom

Thomas Peter Matthews

USPTO Granted Patents = 14


 

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • London, GB (2010 - 2022)
  • Sutton, GB (2011 - 2023)

Company Filing History:

goldMedal14 out of 262 
 
Cancer Research Technology Limited
 patents
silverMedal6 out of 24 
 
The Institute of Cancer Research
 patents
bronzeMedal5 out of 68 
 
Vernalis &r&d) Ltd.
 patents
4. 1 out of 7 
 
Vernalis (cambridge) Limited
 patents
where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 11787792 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof (2023-10-17),
2. 11234987 - Isoxazole compounds as inhibitors of heat shock proteins (2022-02-01),
3. 10413550 - Isoxazole compounds as inhibitors of heat shock proteins (2019-09-17),
4. 10259806 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof (2019-04-16),
5. 9765059 - 5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use (2017-09-19),
6. 9718793 - Isoxazole compounds as inhibitors of heat shock proteins (2017-08-01),
7. 9663503 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof (2017-05-30),
8. 9403797 - 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use (2016-08-02),
9. 9040540 - 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use (2015-05-26),
10. 8507480 - Isoxazole compounds as inhibitors of heat shock proteins (2013-08-13),
11. 8450310 - Isoxazole compounds as inhibitors of heat shock proteins (2013-05-28),
12. 8367658 - Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use (2013-02-05),
13. 8058045 - Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use (2011-11-15),
14. 7705027 - Isoxazole compounds as inhibitors of heat shock proteins (2010-04-27),

Title: Thomas Peter Matthews: Pioneering Innovations in Therapeutic Compounds

Introduction:

Thomas Peter Matthews, a prolific inventor based in Sutton, GB, has made significant contributions to the field of therapeutic compounds through his groundbreaking innovations. With a total of 14 patents to his name, Matthews continues to push the boundaries of science and medicine with his latest inventions.

Latest Patents:

Matthews' recent patents include the development of 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile compounds. These compounds, known as 'TFM compounds', have shown promising results in inhibiting the function of Checkpoint Kinase 1 (CHK1) kinase, opening new possibilities in the treatment of various diseases, including cancer. Additionally, his work on Isoxazole compounds as inhibitors of heat shock proteins represents a significant advancement in the field of cancer treatment.

Career Highlights:

Matthews has been associated with esteemed institutions such as Cancer Research Technology Limited and The Institute of Cancer Research, where he has conducted groundbreaking research in the development of novel therapeutic compounds. His dedication to advancing the field of medicine has earned him recognition as a visionary inventor in the industry.

Collaborations:

Throughout his career, Matthews has collaborated closely with esteemed colleagues such as Ian James Collins and Kwai Ming Cheung. These collaborations have led to synergistic efforts in research and development, resulting in innovative solutions that have the potential to revolutionize the way we approach disease treatment.

Conclusion:

In conclusion, Thomas Peter Matthews stands as a beacon of innovation in the realm of therapeutic compounds. His relentless pursuit of scientific excellence and his unwavering dedication to improving human health underscore his status as a trailblazing inventor. As Matthews continues to innovate and inspire, his contributions are poised to shape the future of medicine for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…